BiotechTube
Home/Pipeline/Lighthouse Pilot Product

Lighthouse Pilot Product

Not Specified

PilotLaunched 2020

Key Facts

Indication
Not Specified
Phase
Pilot
Status
Launched 2020
Company
Cipherome

About Cipherome

Founded in 2015 in Silicon Valley, Cipherome aims to accelerate precision medicine by simplifying complex healthcare data analysis. The company has evolved from a pharmacogenomics focus to offering the COMPASS platform, a comprehensive tool for clinical research, genomic analysis, and AI model training. Cipherome has conducted clinical validation studies with prestigious institutions and is actively commercializing its platform while contributing to healthcare data science education.

View full company profile

Therapeutic Areas

PharmacogenomicsPrecision Medicine

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved